Hormone pellet therapy is one of the most patient-preferred delivery methods in the BHRT space - and one of the most misunderstood by providers who have not yet worked with it. For clinicians considering adding pellets to their practice, or those who are early in their pellet therapy experience, understanding the pharmacology and clinical rationale behind this delivery method is the foundation for doing it well.
This article covers how pellet therapy works at the physiologic level, why patients consistently report higher satisfaction with pellets compared to other delivery methods, how to identify ideal candidates, and what providers need to know before getting started.
WHAT IS PELLET THERAPY?
Hormone pellets are small, cylindrical implants - roughly the size of a grain of rice - that are compounded from bioidentical hormones, most commonly testosterone and estradiol. They are inserted subcutaneously through a minor in-office procedure, typically in the upper buttock or hip area, using a trocar under local anesthesia.
Once inserted, pellets dissolve gradually over three to six months, releasing hormones continuously into the surrounding tissue and bloodstream. The pellet is fully absorbed by the body - there is nothing to remove when it is done. The patient simply returns for a new insertion when levels begin to decline, typically every three to five months for women and every four to six months for men.
THE PHARMACOLOGY OF STEADY-STATE DELIVERY
The key pharmacologic advantage of pellet therapy is its ability to provide steady-state hormone levels over an extended period. This is fundamentally different from the pharmacokinetic profile of other delivery methods.
Injectable testosterone, for example, produces a significant spike in serum testosterone levels in the days immediately following injection, followed by a gradual decline back toward baseline over the following week or two. This peak-and-trough pattern means patients often feel their best in the first few days post-injection and progressively worse as the injection date approaches. For some patients, this variability is barely noticeable. For others, it significantly affects mood, energy, libido, and overall quality of life.
Pellets release hormones in a manner that more closely approximates physiologic secretion. Hormone release from the pellet is influenced by cardiac output - meaning that during physical activity, when blood flow to the tissue increases, slightly more hormone is released. At rest, release slows. This activity-responsive delivery pattern is unique to pellets and is one reason why patients often describe feeling more like themselves on pellet therapy than on other modalities.
Because levels remain relatively stable between insertions, patients avoid the symptom fluctuation that is a common complaint with injections, creams, and patches. This stability is a major driver of the high patient satisfaction and retention rates associated with pellet therapy.
WHY PATIENTS PREFER PELLETS
Patient satisfaction data in the pellet therapy literature consistently shows higher rates of satisfaction compared to other hormone delivery methods. Several factors drive this.
Convenience is the most commonly cited reason. Once the pellet is inserted, the patient does nothing for the next three to five months. There are no daily creams to apply, no patches to remember, no injections to schedule. For busy patients - and most patients are busy - this simplicity is highly valued.
Consistency of symptom relief is the second major factor. Patients who have previously experienced the ups and downs of injection therapy or the variability of topical absorption often describe pellet therapy as the first method that made them feel consistently well. The absence of hormone fluctuation translates directly to more stable mood, energy, libido, and cognitive function.
The minimally invasive nature of the procedure is also well received. Most patients experience minimal discomfort during insertion under local anesthesia, and downtime is limited to avoiding submersion in water and strenuous lower body exercise for a few days post-procedure. The majority of patients return for repeat insertions without hesitation.
IDEAL CANDIDATES FOR PELLET THERAPY
Not every patient is an ideal pellet candidate, and part of practicing competently in this space is being able to identify who will benefit most.
Strong candidates for pellet therapy include patients who have experienced symptom fluctuation or inconsistent relief on other hormone delivery methods, patients who have compliance challenges with daily or weekly regimens, patients who prioritize convenience and want a low-maintenance approach to hormone optimization, and patients who are already motivated and engaged in their hormone health journey and are likely to return for follow-up insertions.
Pellet therapy is particularly well suited for patients who are physically active, since the activity-responsive hormone release mechanism may provide additional benefit for this population.
Patients who may not be ideal candidates include those who want the ability to quickly adjust or discontinue hormone therapy, since pellets cannot be removed once inserted. Patients who are very early in their hormone therapy journey and whose optimal dose has not yet been established may also benefit from starting with a more easily adjustable delivery method before transitioning to pellets.
WHAT PROVIDERS NEED TO KNOW BEFORE GETTING STARTED
Adding pellet therapy to a practice requires preparation that goes beyond learning the insertion technique. Providers new to pellets should understand the following.
Sourcing and compounding pharmacy relationships. Pellets must be sourced from a licensed compounding pharmacy. Establishing a relationship with a reputable 503A or 503B pharmacy that produces consistent, high-quality pellets is foundational. Pellet quality varies between compounders, and inconsistency in pellet composition directly affects patient outcomes.
Dosing calculations. Pellet dosing is not one-size-fits-all. Doses are calculated based on the patient's lab values, symptoms, body weight, and prior hormone therapy history. Underdosing leads to inadequate symptom relief. Overdosing can cause supraphysiologic levels that create their own set of problems - particularly in women receiving testosterone pellets. Learning to dose accurately and adjusting based on follow-up labs is a skill that develops with experience.
Procedural training. While pellet insertion is a minor procedure, it requires proper technique to minimize complications such as extrusion, infection, and bruising. Hands-on training with an experienced pellet provider is strongly recommended before performing insertions independently.
Informed consent and documentation. Patients should understand that pellets cannot be removed, that levels will peak and then gradually decline over the insertion interval, and that it may take one to two insertion cycles to dial in the optimal dose. Thorough informed consent documentation protects both the patient and the provider.
PELLET THERAPY AS A PRACTICE REVENUE STREAM
From a practice business perspective, pellet therapy offers a compelling revenue model. The insertion procedure itself is a cash-pay service that commands a meaningful fee. Patients return every three to six months, creating predictable recurring revenue. Patient retention in pellet programs is high because satisfaction rates are high - patients who feel well on pellet therapy do not typically seek care elsewhere.
For providers building or scaling a cash-pay hormone practice, pellet therapy is one of the highest-retention services available.
BOTTOM LINE
Pellet therapy works because it delivers hormones consistently, conveniently, and in a manner that closely approximates physiologic secretion. Patients love it because it eliminates the compliance burden and symptom variability of other delivery methods. Providers who learn to do it well - with accurate dosing, quality sourcing, and proper technique - build loyal patient populations and sustainable practice revenue.
